CD8A and melanoma: Of these predicted neopeptides, we detected specific CD8+ T cell recognition toward 204 neoepitopes in either TIL Inf products or PBMC samples from melanoma patients, while the remaining 5717 were not recognized by T cells in the evaluated patients (Figure 6A).